HongShan, the rebranded venture capital arm formerly known as Sequoia Capital China, has emerged as the leading investor in China's explosive embodied AI robotics boom, participating in 20 financing rounds across 14 companies in just six months. This aggressive positioning reflects a broader shift in how the world's largest venture capital firms are betting on physical-world artificial intelligence, even as questions linger about whether these robots can actually make money.

Why Is China's Robot Funding Exploding Right Now?

China's embodied AI sector, which develops robots capable of perceiving, reasoning, and physically interacting with the world, attracted CNY93.5 billion, or approximately USD13.8 billion, in financing during the first half of 2026. This represents a fivefold increase compared to the same period a year earlier. The sector recorded 322 financing events during those six months, more than doubling from the prior year, signaling that investor enthusiasm for robot startups has shifted from niche interest to mainstream capital allocation.

Three major forces are driving this surge. First, breakthroughs in large language models (LLMs), which are AI systems trained on vast amounts of text to understand and generate human language, have made robots smarter and more capable of understanding complex instructions. Second, leading companies in the space are preparing for initial public offerings (IPOs), creating exit opportunities that attract fresh capital. Third, Chinese government policy support has encouraged investment in the sector as a strategic priority.

Which Companies Are Winning the Funding Race?

The funding has concentrated in three specific areas that investors believe will unlock commercial viability: research and development of embodied AI large language models, large-scale data collection to train those models, and product delivery capabilities that can actually deploy robots at scale.

The rapid pace of fundraising has created a wave of new unicorns, companies valued at over USD1 billion. Three humanoid robot developers, Unitree Robotics, AgiBot, and Galbot, achieved unicorn status last year. This year, another 19 embodied AI companies have reached unicorn status, including Deep Robotics, X Square Robot, AI² Robotics, Galaxea AI, and Spirit AI. Among these, Galbot, X Square Robot, AI² Robotics, and Galaxea AI have each surpassed valuations of CNY20 billion, or approximately USD2.9 billion.

Beyond venture capital, state-backed and industrial investors have stepped up participation. The National Artificial Intelligence Industry Investment Fund has invested in companies including Galbot and Deep Robotics, while local government-backed investors, particularly Shenzhen Capital Group, have invested in at least 12 companies. Automotive manufacturers, including SAIC Motor and BAIC Group Industrial Investment, have also participated in financing rounds.

China's internet giants are also competing aggressively. Meituan and its affiliated entities were the most active corporate investors, backing seven companies, including X Square Robot, Galaxea AI, and TARS Robotics. Tencent Holdings, Alibaba Group Holding, and JD.Com also participated in multiple funding rounds. X Square Robot has become the only embodied AI company in China to receive strategic investments from Meituan, Alibaba, ByteDance, and Xiaomi simultaneously.

How Are Investors Positioning for IPO Success?

The IPO pipeline is substantial. Data from financial platform Choice show that 10 robotics-related companies completed listings in Hong Kong during the first half of 2026, while another 16 have submitted listing applications and are awaiting approval. In China's domestic A-share market, Unitree Robotics, Deep Robotics, Leju Robotics Technology, and Dobot Robotics have all formally entered the initial public offering process.

This IPO activity is reshaping how venture investors approach the sector. Companies that can demonstrate a clear path to profitability and scale are attracting the largest funding rounds, while those still in the research phase face increasing scrutiny about their commercial viability.

What Are Experts Warning About the Robot Boom?

Despite the enthusiasm, industry participants are cautious about the sustainability of current valuations. Multiple insiders interviewed by Yicai, a leading Chinese financial news platform, stated that large-scale robot deployment is not yet commercially viable. However, they noted that once a company successfully establishes a workable business model, it could mark the beginning of an industry consolidation phase.

"If embodied intelligence remains limited to demonstrations, marketing, and research fields, it will only have short-term commercial value. As valuations continue to rise, the bubble will only get bigger," said Liu Yinghang, a partner at Scale Partners.

Liu Yinghang, Partner at Scale Partners

Liu added that the market's real demand is for embodied AI technologies capable of solving problems in real-world scenarios, not just impressive lab demonstrations.

Steps to Understanding the Robot Funding Landscape

• Track IPO Pipelines: Monitor which robotics companies have submitted listing applications in Hong Kong and China's A-share market, as IPO success will validate whether these startups can achieve sustainable profitability at scale.
• Evaluate Commercial Deployment: Assess whether companies are moving beyond research demonstrations and marketing into actual large-scale deployment with paying customers in real-world scenarios.
• Monitor Consolidation Signals: Watch for announcements of mergers, acquisitions, or company failures, which will indicate whether the industry is entering a shakeout phase after the current funding boom.
• Follow State Investment Patterns: Track which companies receive backing from the National Artificial Intelligence Industry Investment Fund and local government investors, as these signals often precede broader market adoption.

HongShan's aggressive positioning in embodied AI reflects a broader recognition among top-tier venture firms that physical-world robotics represents the next frontier for artificial intelligence investment, even if the path to profitability remains uncertain. The firm's participation in 20 financing rounds across 14 companies in just six months demonstrates that Sequoia's China operation is betting heavily that at least some of these robot startups will eventually prove the skeptics wrong.